¼öÀÇ Á¾¾ç Áø´Ü¾à ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : µ¿¹° À¯Çüº°, °Ë»ç À¯Çüº°, ¾Ï À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Veterinary Oncology Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Test Type, By Cancer Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1654229
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼öÀÇ Á¾¾ç Áø´Ü ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ ¼öÀÇ Á¾¾ç Áø´Ü ½ÃÀåÀº 2025-2030³â¿¡ CAGR 8.4%¸¦ ±â·ÏÇϸç, 2030³â±îÁö 34¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ½ÃÀåÀº ÁÖ·Î µ¿¹° Àα¸ ¹× »çÀ°·ü Áõ°¡, µ¿¹°¿¡ ´ëÇÑ ÁöÃâ Áõ°¡, ¿¹¹æÀû µ¿¹° ÇコÄɾî·ÎÀÇ ÃÊÁ¡ Àüȯ, ¼öÀÇÇÐ ¾Ï Áø´Ü °Ë»çÀÇ ¹ßÀü, Çõ½ÅÀûÀÎ Á¦Ç° Ãâ½Ã¸¦ À§ÇÑ µ¿¹° °Ç°­Áø´Ü¿¡ ´ëÇÑ ¿¬±¸°³¹ß ÅõÀÚ Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 12¿ù Pet Preferred Diagnostics´Â 21Á¾ÀÇ Á¾¾ç°ú 14Á¾ÀÇ ½Å°æÁúȯ°ú °ü·ÃµÈ 11Á¾ÀÇ Æ¯Á¤ Á¾¾ç Ç×ü¸¦ °ËÃâÇÏ´Â °³¿Í °í¾çÀ̸¦ À§ÇÑ È¹±âÀûÀÎ Á¶±â ¾Ï Áø´Ü Å×½ºÆ®¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ °í°¨µµ Ç÷ûÇÐÀû °Ë»ç´Â ÀÓ»ó Áõ»óÀÌ ³ªÅ¸³ª±â Àü¿¡ ¾Ç¼º Á¾¾çÀ» ã¾Æ³»¾î Á¶±â Ä¡·á°¡ °¡´ÉÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ °Ë»ç´Â ´Ù¾çÇÑ Á¾¾ç°ú ½Å°æÁúȯÀ» °¨º°ÇÒ ¼ö ÀÖ´Â ¼öÀÇÇп¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â À¯ÀÏÇÑ °Ë»ç·Î, ºñħ½ÀÀûÀ̰í, Àú·ÅÇϸç, 24½Ã°£ À̳»¿¡ °á°ú¸¦ ¾òÀ» ¼ö ÀÖ´Â ½Å¼ÓÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

¶ÇÇÑ OncotectÀÇ ¼¼°è ÃÖÃÊÀÌÀÚ À¯ÀÏÇÑ °¡Á¤¿ë ¾Ï °ËÁø °Ë»ç µî ÷´Ü ¹Ý·Áµ¿¹° ¾Ï Áø´Ü °Ë»çÀÇ °³¹ßÀº ¹Ý·Áµ¿¹° ¾Ï Áø´Ü ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ÀÌ Çõ½ÅÀûÀÎ ¹Ý·Á°ß ¾Ï ¼±º° °Ë»ç´Â Á¶±â ¹ß°ßÀ» °¡´ÉÇÏ°Ô Çϰí, Ä¡·á ¼ºÀûÀ» Çâ»ó½Ã۸ç, º¸È£ÀÚ¿¡°Ô ¾Èµµ°¨À» ÁÝ´Ï´Ù. Oncotect´Â °¡Àå ÈçÇÑ 4À¯ÇüÀǰ³ ¾ÏÀ» °ËÃâÇÏ´Â Oncotect´Â °¡Á¤°ú µ¿¹°º´¿ø¿¡¼­ ¸ðµÎ »ç¿ëÇÒ ¼ö ÀÖÀ¸¸ç, »ç¿ëÀÚ Ä£È­ÀûÀÌ°í »ç¿ëÇϱ⠽±½À´Ï´Ù. °¡Á¤³» °Ë»ç ¼Ö·ç¼Ç Áõ°¡´Â Á¤È®¼ºÀ» Áö¿øÇÏ´Â ÀÓ»ó µ¥ÀÌÅÍ¿Í ÇÔ²² ƯÈ÷ ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó ¼öÀÇÇÐ ¾Ï Áø´Ü ½ÃÀåÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù.

The Veterinary Cancer Society(¼öÀǾÏÇùȸ)¿¡ µû¸£¸é ¾ÏÀº °³, ƯÈ÷ 10¼¼ ÀÌ»ó °³ÀÇ 47%, °í¾çÀÌÀÇ 32%°¡ ¾ÏÀ¸·Î »ç¸ÁÇÏ´Â °¡Àå Å« ¿øÀÎÀ¸·Î ²ÅÈü´Ï´Ù.°³ ¾à 4¸¶¸® Áß 1¸¶¸®´Â ÀÏ»ý µ¿¾È Á¶Á÷ÀÇ ºñÁ¤»óÀûÀÎ Áõ½Ä, Áï ½Å »ý¼ºÀ» °æÇèÇÕ´Ï´Ù. ¹Ý·Áµ¿¹°¿¡´Â 100°¡Áö¿¡ °¡±î¿î ¾ÏÀÌ Á¸ÀçÇϹǷΠÁø´Ü¿¡ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖÁö¸¸, ¼öÀÇÇÐÀÇ ¹ßÀüÀ¸·Î °³¿Í °í¾çÀÌ ¸ðµÎ Ä¡·á ¼º°ø·üÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. È£ÁÖ ¿¬±¸ µ¥ÀÌÅÍ Ä¿¸ÕÁî(ARDC)ÀÇ 2024³â 5¿ù Á¶»ç¿¡ µû¸£¸é È£ÁÖ¿¡¼­´Â°³ 4¸¶¸® Áß 1¸¶¸®, °í¾çÀÌ 5¸¶¸® Áß 1¸¶¸®°¡ ¾Ï¿¡ °É¸° °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â 2024³â¿¡ ¾à 600¸¸ ¸¶¸®ÀÇ ¹Ý·Á°ßÀÌ ¾Ï Áø´ÜÀ» ¹ÞÀ» °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¹Ý·Áµ¿¹°°ú »ç¶÷ ¸ðµÎ ¾Ï Áø´ÜÀ» °³¼±ÇÒ ¼ö ÀÖ´Â ¶Ç ´Ù¸¥ ±âȸ°¡ »ý°å´Ù°í The Cancer Letter Inc.´Â º¸°íÇß½À´Ï´Ù. ¶ÇÇÑ ¹Ì±¹¼öÀÇ»çȸ´Â 4¸¶¸® Áß 1¸¶¸®ÀÇ °³°¡ ¾ðÁ¨°¡´Â ½Å»ý¹°·Î ¹ßÀüÇÒ °ÍÀ̸ç, 10¼¼ ÀÌ»ó ¹Ý·Á°ßÀÇ ¾à Àý¹ÝÀÌ ¾Ï¿¡ °É¸± °ÍÀ̶ó°í ¹àÇû½À´Ï´Ù.

¼öÀÇÇÐ ¾Ï Áø´Ü ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ¼öÀÇ Á¾¾ç Áø´Ü ½ÃÀåÀÇ º¯µ¿ µ¿Çâ°ú ¹üÀ§

Á¦4Àå ¼öÀÇ Á¾¾ç Áø´Ü ½ÃÀå : µ¿¹° À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¼öÀÇ Á¾¾ç Áø´Ü ½ÃÀå : °Ë»ç À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¼öÀÇ Á¾¾ç Áø´Ü ½ÃÀå : ¾Ï À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ¼öÀÇ Á¾¾ç Áø´Ü ½ÃÀå : ÃÖÁ¾ ¿ëµµÀÇ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå ¼öÀÇ Á¾¾ç Áø´Ü ½ÃÀå : ±¹°¡ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ÁÖ¿ä Æ÷ÀÎÆ®

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Veterinary Oncology Diagnostics Market Growth & Trends:

The global veterinary oncology diagnostics market is expected to reach USD 3.45 billion by 2030, registering a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by growing animal population and ownership rates, increased expenditure on animals, shifting focus on preventative animal healthcare, advances in veterinary cancer diagnostic testing, and rising R&D investment in animal health diagnostics to launch innovative products. For instance, in December 2024, Pet Preferred Diagnostics introduced a groundbreaking early cancer diagnostic test for dogs and cats that detects 11 specific onconeural antibodies linked to 21 types of tumors and 14 neurological diseases. This highly sensitive serological test can identify malignancy, often before clinical signs appear, enabling early treatment. It is the only test available in veterinary medicine that differentiates various tumors and neurological conditions, offering a non-invasive, affordable, and quick solution with a 24-hour turnaround.

Additionally, the development of advanced veterinary cancer diagnostic tests, such as the world's first and only at-home cancer screening test by Oncotect, is creating lucrative opportunities in the veterinary oncology diagnostics market. This innovative canine cancer screening test enables early detection, improving treatment outcomes and offering peace of mind to pet owners. Oncotect, which detects the four most prevalent types of canine cancer, can be used at home or in-clinic, making it user-friendly and accessible. The rise in at-home testing solutions, coupled with clinical data supporting its accuracy, is expanding the market for veterinary oncology diagnostics, particularly by increasing accessibility for pet parents.

Furthermore, the increasing prevalence of cancer in pets is significantly driving the growth of the veterinary oncology diagnostics market. As per The Veterinary Cancer Society, Cancer is the top reason of death in 47% of canines, particularly those over 10 years old, and in 32% of felines. Around 1 in 4 dogs will experience abnormal tissue growth, or neoplasia, during their lifetime. With nearly 100 types of cancer affecting pets, a diagnosis can be overwhelming, yet advances in veterinary care have improved treatment success rates for both dogs and cats. Similarly, cancer is the leading cause of death in cats and dogs, affecting one in four dogs and one in five cats in Australia, according to a May 2024 study by the Australian Research Data Commons (ARDC). In the U.S., about 6 million pet dogs are expected to be diagnosed with cancer in 2024, creating a unique opportunity to improve cancer diagnosis for both pets and humans, as reported by The Cancer Letter Inc. Additionally, the American Veterinary Association states that one in four dogs will develop neoplasia at some point, and about half of dogs over the age of 10 will develop cancer.

Veterinary Oncology Diagnostics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Veterinary Oncology Diagnostics Market Variable Trends & Scope

Chapter 4. Veterinary Oncology Diagnostics Market: Animal Type Estimates & Trend Analysis

Chapter 5. Veterinary Oncology Diagnostics Market: Test Type Estimates & Trend Analysis

Chapter 6. Veterinary Oncology Diagnostics Market: Cancer Type Estimates & Trend Analysis

Chapter 7. Veterinary Oncology Diagnostics Market: End Use Estimates & Trend Analysis

Chapter 8. Veterinary Oncology Diagnostics Market: Country Estimates & Trend Analysis

Chapter 9. Competitive Landscape

Chapter 10. Key Takeaways

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â